Compound Profile
Valepotriates
Valerian iridoid ester fraction associated with sedative and stress signaling effects.
Last reviewed:
C PreliminaryMonograph visual
Valepotriates
Generated profile category visual
Where to go next — guides & comparisons
Continue reading
- If you want help sleeping → Sleep guides
- If you want help with anxiety or stress → Anxiety & stress guides
- If you want to browse more compounds → All compounds
Quick Stats
Evidence level
Limited evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Safety review pending
Best for
GABA A Signaling, Adenosine Signaling, CNS Calming Pathways
Found In
Botanicals that contain Valepotriates, with full herb profiles.
Safety & Cautions
Evidence mostly comes from valerian extracts. Sedation and additive effects with CNS depressants are key concerns.
Evidence Summary
C PreliminaryEvidence lens
Early signal that needs stronger human replication before practical claims.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Neurotransmitter Modulation · Vascular Function Support
Research maturity: Preliminary or mixed — main contexts: GABA A Signaling · Adenosine Signaling · CNS Calming Pathways
Safety boundary: Safety note available — Evidence mostly comes from valerian extracts.
Confidence estimate based on the design quality and consistency of published clinical trials.
Valepotriates has a limited evidence evidence rating.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
How Valepotriates Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Valepotriates Works
Mechanisms & Biological Pathways▼
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Condition guides
Continue exploring
Related research paths
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Review available sources for Valepotriates
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Related alternatives
Herbs for similar conditions
Tradeoffs
Free safety checklist
Get the Valepotriates evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Compound profile context
How to interpret Valepotriates
Valepotriates dosage by use case, onset and duration, safety limits, and interactions for gaba a signaling, graded against research. Limited Human Evidence… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Valepotriates, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.